Zobrazeno 1 - 10
of 1 992
pro vyhledávání: '"GLP-1 receptor agonists"'
Autor:
HamaSalih RM
Publikováno v:
Cancer Management and Research, Vol Volume 16, Pp 731-740 (2024)
Raz Muhammed HamaSalih Department of Pharmacology and Toxicology, College of Pharmacy, University of Sulaimani, Slemani, Kurdistan Region, IraqCorrespondence: Raz Muhammed HamaSalih, College of Pharmacy, University of Sulaimani, Town Campus, Slemani,
Externí odkaz:
https://doaj.org/article/893c3079c1f1486788de800b5a09c269
Autor:
Zhiyuan Cheng, Shuang Wang, Fu‐rong Li, Cheng Jin, Chunbao Mo, Jing Zheng, Xia Li, Fengchao Liang, Jinkui Yang, Dongfeng Gu
Publikováno v:
Journal of Diabetes, Vol 16, Iss 10, Pp n/a-n/a (2024)
Abstract Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs), a class of injectable antidiabetic drugs, have shown significant efficacies in improving glycemic and weight control in patients with type 2 diabetes (T2D). However, the
Externí odkaz:
https://doaj.org/article/bb757573ac26405dbf27de4cef7c0d18
Autor:
Mohamed E. A. Mostafa, Tariq Alrasheed
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
BackgroundType 2 diabetes mellitus (T2DM) is linked to a heightened likelihood of experiencing fractures. It is crucial to ascertain whether medications used to lower blood sugar levels can elevate the risk of fractures. We aimed to investigate and c
Externí odkaz:
https://doaj.org/article/47f21d418b0641ccab2fd0fcc4196bbf
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
BackgroundThe escalating global economic burden of ischemic stroke poses a significant public health challenge amid global aging trends. The broad therapeutic efficacy of new antidiabetic drugs may offer new options in the prevention and treatment of
Externí odkaz:
https://doaj.org/article/098676a1cb96438992299aa2678a1373
Autor:
Khushboo Gala, Wissam Ghusn, Vitor Brunaldi, Christopher McGowan, Reem Z. Sharaiha, Daniel Maselli, Brandon Vanderwel, Prashant Kedia, Michael Ujiki, Eric Wilson, Eric J. Vargas, Andrew C. Storm, Barham K. Abu Dayyeh
Publikováno v:
Obesity Pillars, Vol 11, Iss , Pp 100112- (2024)
Background: To evaluate the weight loss outcomes of the large US cohort of patients undergoing endoscopic sleeve gastroplasty (ESG) with or without concomitant anti-obesity (AOM) use. Methods: We performed a retrospective analysis of adult patients w
Externí odkaz:
https://doaj.org/article/58909b3f80074c579a1ef39ac2c58a7e
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 40, Iss 3, Pp 212-220 (2024)
Abstract Several recent advances provide multiple health benefits to individuals with type 2 diabetes mellitus (T2DM). Pharmacological therapy is governed by person‐centered factors, including comorbidities and treatment goals. Adults with T2DM who
Externí odkaz:
https://doaj.org/article/4c0c7199c3a84367bd4074b97c00b66c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Matheo A. M. Stumpf, Marcio C. Mancini
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 68 (2024)
ABSTRACT Obesity is a prevalent chronic disease. The management of extreme obesity – i.e., body mass index (BMI) ≥ 50 kg/m2 or obesity class IV and V – is still far from ideal. Individuals with extreme obesity have a high risk of surgical compl
Externí odkaz:
https://doaj.org/article/cfe29782d66649c8944c6d6466fad029
Autor:
Yoko Narasaki, Csaba P. Kovesdy, Amy S. You, Keiichi Sumida, Yamini Mallisetty, Satya Surbhi, Fridtjof Thomas, Alpesh N. Amin, Elani Streja, Kamyar Kalantar-Zadeh, Connie M. Rhee
Publikováno v:
The Lancet Regional Health. Americas, Vol 36, Iss , Pp 100814- (2024)
Summary: Background: We examined the real-world comparative safety of sodium-glucose cotransporter-2 inhibitors (SGLT2i) vs. other newer anti-glycemic medications (dipeptidyl peptidase-4 inhibitors [DPP4i], glucagon-like peptide-1 receptor agonists [
Externí odkaz:
https://doaj.org/article/578ff3bab1c544c8928fcc8422957606